A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. (IRIS)

This study has been completed.
Cancer Research UK
Information provided by (Responsible Party):
Imperial College London
ClinicalTrials.gov Identifier:
First received: February 4, 2013
Last updated: March 23, 2015
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)